Progenity Revenue and Competitors

Claim your profile



Total Funding



Estimated Revenue & Valuation

  • Progenity's estimated annual revenue is currently $45M per year.(i)
  • Progenity received $125.0M in venture funding in November 2017.
  • Progenity's estimated revenue per employee is $293,791
  • Progenity's total funding is $248.5M.

Employee Data

  • Progenity has 153 Employees.(i)
  • Progenity grew their employee count by -70% last year.
Competitor NameRevenueNumber of EmployeesEmployee GrowthTotal FundingValuation
Add Company

Progenity helps patients and their families Prepare for Life, with medically relevant health information starting before conception, through pregnancy, childhood, and adulthood. Using our highly-complex molecular diagnostic testing, healthcare providers can access the most advanced genomic technology to guide patient care at critical life stages.

keywords:Biotechnology,Healthcare,Medical Diagnostics


Total Funding


Number of Employees


Revenue (est)


Employee Growth %





Progenity News

2022-04-17 - Progenity Appoints Paul Shabram to Lead Technical Operations of the Company’s Ingestible Drug/Device Platforms

Progenity Appoints Paul Shabram to Lead Technical Operations of the Company's Ingestible Drug/Device Platforms. Progenity, Inc. Mon, April 25,...

2022-04-17 - Progenity, Inc. (NASDAQ:PROG) Given Consensus ...

Progenity, Inc, a biotechnology company, provides develops and commercializes molecular testing products in the United States. The company...

2022-03-30 - Progenity Announces Two Poster Presentations at Controlled ...

Progenity, Inc. is a biotechnology company innovating in the fields of gastrointestinal health and oral biotherapeutics and is developing a...

2021-11-23 - Progenity Gets $44 Million in Warrant Exercises Since August

By Chris Wack Progenity Inc. said it has received more than $44 million in warrant exercises since August. The biotechnology company said that as a result of previously issued warrants being exercised and other capital-raising transactions, it believes its current liquidity position provides s ...

2021-10-12 - Progenity : announces it has successfully been assigned a patent for the treatment of a disease of the gastrointestinal tract

Patent number: 11134889 Abstract: This disclosure features methods and compositions for treating diseases of the gastrointestinal tract with a SMAD7 inhibitor. Type: Grant Filed: December 14, 2017 Date of Patent: October 5, 2021 Assignee: Progenity, Inc. Inventors: Mitchell Lawrence Jones ...

Company NameRevenueNumber of EmployeesEmployee GrowthTotal Funding

Progenity Funding

DateAmountRoundLead InvestorsReference
2017-11-08$125.0MBAthyrium Capital ManagementArticle